Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Weber MS, Buttmann M, Meuth SG, Dirks P, Muros-Le Rouzic E, Eggebrecht JC, Hieke-Schulz S, Leemhuis J, Ziemssen T.

Verlag

Publisher-Information
Front Neurol. 2022 May 9;13:863105.

Link

Zur Publikation (externer Server)
https://doi.org/10.3389/fneur.2022.863105

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2022